Updated December 9, 2021
Links in the original post broke.
You might also like:
--- the original post follows below ---
FDA is focusing on cGMP compliance by food and drug manufacturers.
FDA investigative chief eyes manufacturing practices:
"John Roth, director of the FDA's Office of Criminal Investigations, said officials are seeking to ensure that companies are appropriately balancing their profit motives with the need to manufacture food and drugs responsibly.
The meningitis outbreak and other recent cases have spurred the agency to take a closer look at this balance, Roth told lawyers at an American Bar Association-sponsored conference in Las Vegas focused on white-collar crime.
"We wonder exactly if this is a systemic problem, if it requires a broader response by the FDA or is it an anomaly," Roth said in a panel discussion Friday. "We're going to be taking a look at that and hopefully we'll launch in a thoughtful way.""
'via Blog this'
You might also be interested in:
On the FDA website - FD&C Act Chapter III: Prohibited Acts and Penalties
Return Home:
The Health, Drug, Prescription, and GMP Supersite Blog
SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
SkillsPlus Intl Info Blog
The Exemptee Institute
The Designated Representative Institute
The Health, Drug, Prescription, and GMP Supersite Gift Store
.png "SkillsPlus International Inc. logo")
Posts
